A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer Meeting Abstract


Authors: Shaffer, D. R.; Abrey, L.; Beekman, K.; Morris, M.; Eicher, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Rosen, N.; Scher, H. I.
Abstract Title: A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer
Meeting Title: 13th European Cancer Conference (ECCO 13)
Journal Title: EJC Supplements
Volume: 3
Issue: 2
Meeting Dates: 2005 Oct 30-Nov 3
Meeting Location: Paris, France
ISSN: 1359-6349
Publisher: Pergamon-Elsevier Science Ltd  
Date Published: 2005-01-01
Start Page: 419
Language: English
ACCESSION: WOS:000247564801601
PROVIDER: wos
DOI: 10.1016/S1359-6349(05)81740-9
Notes: --- - Meeting Abstract: 1449 - S - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kathleen Woodruff Beekman
    12 Beekman
  2. Neal Rosen
    425 Rosen
  3. Susan Slovin
    254 Slovin
  4. Michael Morris
    577 Morris
  5. William K Kelly
    115 Kelly
  6. David Solit
    778 Solit
  7. Lauren E Abrey
    278 Abrey
  8. Howard Scher
    1130 Scher
  9. David R Shaffer
    25 Shaffer
  10. Caitlin Eicher
    7 Eicher